nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—ABCC10—Vincristine—muscle cancer	0.0761	0.0964	CbGbCtD
Estradiol—ABCC10—Etoposide—muscle cancer	0.0697	0.0883	CbGbCtD
Estradiol—ABCC10—Doxorubicin—muscle cancer	0.0476	0.0602	CbGbCtD
Estradiol—ABCC10—Methotrexate—muscle cancer	0.0461	0.0583	CbGbCtD
Estradiol—SLCO1C1—Methotrexate—muscle cancer	0.0461	0.0583	CbGbCtD
Estradiol—SLC22A3—Vincristine—muscle cancer	0.045	0.057	CbGbCtD
Estradiol—AOX1—Methotrexate—muscle cancer	0.0436	0.0552	CbGbCtD
Estradiol—CYP1A1—Dacarbazine—muscle cancer	0.034	0.043	CbGbCtD
Estradiol—UGT1A1—Etoposide—muscle cancer	0.0328	0.0415	CbGbCtD
Estradiol—ABCG2—Dactinomycin—muscle cancer	0.0319	0.0404	CbGbCtD
Estradiol—CYP1B1—Doxorubicin—muscle cancer	0.0258	0.0327	CbGbCtD
Estradiol—SLCO1B3—Methotrexate—muscle cancer	0.0257	0.0326	CbGbCtD
Estradiol—SLC22A11—Methotrexate—muscle cancer	0.0238	0.0301	CbGbCtD
Estradiol—ABCG2—Vincristine—muscle cancer	0.0197	0.0249	CbGbCtD
Estradiol—ABCG2—Etoposide—muscle cancer	0.018	0.0228	CbGbCtD
Estradiol—SLCO1A2—Methotrexate—muscle cancer	0.0159	0.0201	CbGbCtD
Estradiol—CYP1A2—Dacarbazine—muscle cancer	0.0152	0.0192	CbGbCtD
Estradiol—SLCO1B1—Methotrexate—muscle cancer	0.015	0.019	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0145	0.0184	CbGbCtD
Estradiol—CYP3A7—Vincristine—muscle cancer	0.0145	0.0184	CbGbCtD
Estradiol—SLC22A8—Methotrexate—muscle cancer	0.0138	0.0175	CbGbCtD
Estradiol—ABCG2—Doxorubicin—muscle cancer	0.0123	0.0156	CbGbCtD
Estradiol—ABCG2—Methotrexate—muscle cancer	0.0119	0.0151	CbGbCtD
Estradiol—ABCB1—Dactinomycin—muscle cancer	0.0115	0.0146	CbGbCtD
Estradiol—CYP3A5—Vincristine—muscle cancer	0.0109	0.0138	CbGbCtD
Estradiol—CYP3A5—Etoposide—muscle cancer	0.00998	0.0126	CbGbCtD
Estradiol—CYP2C8—Etoposide—muscle cancer	0.0096	0.0122	CbGbCtD
Estradiol—ALB—Methotrexate—muscle cancer	0.0082	0.0104	CbGbCtD
Estradiol—CYP1A2—Etoposide—muscle cancer	0.00743	0.00941	CbGbCtD
Estradiol—ABCB1—Vincristine—muscle cancer	0.00709	0.00898	CbGbCtD
Estradiol—ABCB1—Etoposide—muscle cancer	0.0065	0.00823	CbGbCtD
Estradiol—AR—scrotum—muscle cancer	0.00645	0.0854	CbGeAlD
Estradiol—ABCB1—Doxorubicin—muscle cancer	0.00443	0.00561	CbGbCtD
Estradiol—ABCB1—Methotrexate—muscle cancer	0.00429	0.00544	CbGbCtD
Estradiol—CYP3A4—Vincristine—muscle cancer	0.00425	0.00538	CbGbCtD
Estradiol—CYP3A4—Etoposide—muscle cancer	0.00389	0.00493	CbGbCtD
Estradiol—FABP2—embryo—muscle cancer	0.00355	0.047	CbGeAlD
Estradiol—SHBG—hindlimb—muscle cancer	0.00306	0.0406	CbGeAlD
Estradiol—ESRRB—tendon—muscle cancer	0.00277	0.0366	CbGeAlD
Estradiol—CYP3A4—Doxorubicin—muscle cancer	0.00265	0.00336	CbGbCtD
Estradiol—GPER1—smooth muscle tissue—muscle cancer	0.00253	0.0335	CbGeAlD
Estradiol—ESRRB—testis—muscle cancer	0.00229	0.0303	CbGeAlD
Estradiol—GPER1—tendon—muscle cancer	0.0019	0.0252	CbGeAlD
Estradiol—GPER1—vagina—muscle cancer	0.00176	0.0233	CbGeAlD
Estradiol—GPER1—head—muscle cancer	0.00163	0.0216	CbGeAlD
Estradiol—GPER1—testis—muscle cancer	0.00157	0.0208	CbGeAlD
Estradiol—NR1I2—head—muscle cancer	0.00136	0.018	CbGeAlD
Estradiol—ESRRA—renal system—muscle cancer	0.00113	0.015	CbGeAlD
Estradiol—ESRRA—cardiac atrium—muscle cancer	0.00101	0.0134	CbGeAlD
Estradiol—SLCO1C1—renal system—muscle cancer	0.000956	0.0127	CbGeAlD
Estradiol—SLC22A11—renal system—muscle cancer	0.000928	0.0123	CbGeAlD
Estradiol—ESRRA—tendon—muscle cancer	0.000884	0.0117	CbGeAlD
Estradiol—ESRRA—bone marrow—muscle cancer	0.000856	0.0113	CbGeAlD
Estradiol—SLCO1B3—vagina—muscle cancer	0.000844	0.0112	CbGeAlD
Estradiol—ESRRA—vagina—muscle cancer	0.00082	0.0109	CbGeAlD
Estradiol—UGT1A1—renal system—muscle cancer	0.00081	0.0107	CbGeAlD
Estradiol—SLC22A2—renal system—muscle cancer	0.000807	0.0107	CbGeAlD
Estradiol—SLCO4A1—renal system—muscle cancer	0.000766	0.0101	CbGeAlD
Estradiol—ESRRA—head—muscle cancer	0.000757	0.01	CbGeAlD
Estradiol—ESRRA—testis—muscle cancer	0.000732	0.00969	CbGeAlD
Estradiol—SLC22A3—embryo—muscle cancer	0.000719	0.00952	CbGeAlD
Estradiol—ESR2—smooth muscle tissue—muscle cancer	0.000706	0.00934	CbGeAlD
Estradiol—SLCO4A1—cardiac atrium—muscle cancer	0.000686	0.00908	CbGeAlD
Estradiol—ESR2—renal system—muscle cancer	0.000679	0.009	CbGeAlD
Estradiol—SLCO1B1—renal system—muscle cancer	0.000674	0.00893	CbGeAlD
Estradiol—AOX1—renal system—muscle cancer	0.000654	0.00866	CbGeAlD
Estradiol—SLCO1C1—head—muscle cancer	0.00064	0.00847	CbGeAlD
Estradiol—ABCC10—renal system—muscle cancer	0.000636	0.00843	CbGeAlD
Estradiol—SLCO1C1—testis—muscle cancer	0.000618	0.00818	CbGeAlD
Estradiol—ESR1—embryo—muscle cancer	0.000615	0.00814	CbGeAlD
Estradiol—SLCO2B1—renal system—muscle cancer	0.000596	0.00789	CbGeAlD
Estradiol—AOX1—cardiac atrium—muscle cancer	0.000586	0.00775	CbGeAlD
Estradiol—ABCC10—cardiac atrium—muscle cancer	0.00057	0.00755	CbGeAlD
Estradiol—SLC22A1—renal system—muscle cancer	0.00057	0.00754	CbGeAlD
Estradiol—SLC22A3—smooth muscle tissue—muscle cancer	0.000566	0.00749	CbGeAlD
Estradiol—SLCO4A1—vagina—muscle cancer	0.000555	0.00735	CbGeAlD
Estradiol—SLCO1A2—renal system—muscle cancer	0.000549	0.00726	CbGeAlD
Estradiol—SLC22A3—renal system—muscle cancer	0.000544	0.00721	CbGeAlD
Estradiol—SLC22A8—renal system—muscle cancer	0.000524	0.00694	CbGeAlD
Estradiol—CYP1B1—smooth muscle tissue—muscle cancer	0.00052	0.00688	CbGeAlD
Estradiol—SLCO4A1—head—muscle cancer	0.000513	0.00679	CbGeAlD
Estradiol—AOX1—tendon—muscle cancer	0.00051	0.00676	CbGeAlD
Estradiol—CYP1B1—renal system—muscle cancer	0.0005	0.00663	CbGeAlD
Estradiol—SHBG—bone marrow—muscle cancer	0.000499	0.00661	CbGeAlD
Estradiol—ABCC10—tendon—muscle cancer	0.000497	0.00658	CbGeAlD
Estradiol—SLCO4A1—testis—muscle cancer	0.000495	0.00656	CbGeAlD
Estradiol—AR—smooth muscle tissue—muscle cancer	0.000492	0.00652	CbGeAlD
Estradiol—ESR2—vagina—muscle cancer	0.000492	0.00652	CbGeAlD
Estradiol—ESR1—smooth muscle tissue—muscle cancer	0.000483	0.0064	CbGeAlD
Estradiol—ABCC10—bone marrow—muscle cancer	0.000481	0.00637	CbGeAlD
Estradiol—SHBG—vagina—muscle cancer	0.000478	0.00633	CbGeAlD
Estradiol—AR—renal system—muscle cancer	0.000474	0.00628	CbGeAlD
Estradiol—AOX1—vagina—muscle cancer	0.000474	0.00627	CbGeAlD
Estradiol—SLCO2B1—tendon—muscle cancer	0.000465	0.00616	CbGeAlD
Estradiol—ESR1—renal system—muscle cancer	0.000465	0.00616	CbGeAlD
Estradiol—ABCC10—vagina—muscle cancer	0.000461	0.0061	CbGeAlD
Estradiol—ESR2—head—muscle cancer	0.000455	0.00602	CbGeAlD
Estradiol—ESR2—testis—muscle cancer	0.000439	0.00581	CbGeAlD
Estradiol—SHBG—testis—muscle cancer	0.000427	0.00565	CbGeAlD
Estradiol—AR—cardiac atrium—muscle cancer	0.000424	0.00562	CbGeAlD
Estradiol—AOX1—testis—muscle cancer	0.000423	0.0056	CbGeAlD
Estradiol—SLC22A1—vagina—muscle cancer	0.000413	0.00546	CbGeAlD
Estradiol—ABCC10—testis—muscle cancer	0.000411	0.00545	CbGeAlD
Estradiol—SLCO2B1—head—muscle cancer	0.000399	0.00528	CbGeAlD
Estradiol—SLC22A3—vagina—muscle cancer	0.000394	0.00522	CbGeAlD
Estradiol—CYP1B1—tendon—muscle cancer	0.000391	0.00517	CbGeAlD
Estradiol—SLCO2B1—testis—muscle cancer	0.000385	0.0051	CbGeAlD
Estradiol—CYP2C8—renal system—muscle cancer	0.000383	0.00507	CbGeAlD
Estradiol—SLC22A1—head—muscle cancer	0.000381	0.00505	CbGeAlD
Estradiol—AR—tendon—muscle cancer	0.00037	0.0049	CbGeAlD
Estradiol—SLCO1A2—head—muscle cancer	0.000367	0.00486	CbGeAlD
Estradiol—SLC22A3—head—muscle cancer	0.000364	0.00482	CbGeAlD
Estradiol—CYP1A2—renal system—muscle cancer	0.000359	0.00475	CbGeAlD
Estradiol—SLCO1A2—testis—muscle cancer	0.000355	0.00469	CbGeAlD
Estradiol—CYP1A1—renal system—muscle cancer	0.000354	0.00468	CbGeAlD
Estradiol—ALB—testis—muscle cancer	0.000353	0.00467	CbGeAlD
Estradiol—SLC22A3—testis—muscle cancer	0.000352	0.00466	CbGeAlD
Estradiol—SLC22A8—head—muscle cancer	0.00035	0.00464	CbGeAlD
Estradiol—CYP3A5—renal system—muscle cancer	0.000346	0.00458	CbGeAlD
Estradiol—AR—vagina—muscle cancer	0.000343	0.00455	CbGeAlD
Estradiol—ESR1—vagina—muscle cancer	0.000337	0.00446	CbGeAlD
Estradiol—CYP1B1—head—muscle cancer	0.000335	0.00443	CbGeAlD
Estradiol—CYP1B1—testis—muscle cancer	0.000323	0.00428	CbGeAlD
Estradiol—CYP2C19—vagina—muscle cancer	0.000318	0.00421	CbGeAlD
Estradiol—AR—head—muscle cancer	0.000317	0.0042	CbGeAlD
Estradiol—CYP1A1—cardiac atrium—muscle cancer	0.000317	0.0042	CbGeAlD
Estradiol—ESR1—head—muscle cancer	0.000311	0.00412	CbGeAlD
Estradiol—AR—testis—muscle cancer	0.000306	0.00406	CbGeAlD
Estradiol—ESR1—testis—muscle cancer	0.000301	0.00398	CbGeAlD
Estradiol—ABCG2—bone marrow—muscle cancer	0.000282	0.00373	CbGeAlD
Estradiol—CYP2C8—vagina—muscle cancer	0.000278	0.00368	CbGeAlD
Estradiol—ABCG2—vagina—muscle cancer	0.00027	0.00357	CbGeAlD
Estradiol—CYP3A4—renal system—muscle cancer	0.00026	0.00344	CbGeAlD
Estradiol—CYP1A1—vagina—muscle cancer	0.000256	0.00339	CbGeAlD
Estradiol—CYP3A5—vagina—muscle cancer	0.000251	0.00332	CbGeAlD
Estradiol—CYP2C8—testis—muscle cancer	0.000248	0.00328	CbGeAlD
Estradiol—ABCB1—embryo—muscle cancer	0.000243	0.00321	CbGeAlD
Estradiol—ABCG2—testis—muscle cancer	0.000241	0.00319	CbGeAlD
Estradiol—CYP1A1—head—muscle cancer	0.000237	0.00313	CbGeAlD
Estradiol—ABCB1—renal system—muscle cancer	0.000184	0.00243	CbGeAlD
Estradiol—Lethargy—Doxorubicin—muscle cancer	0.000156	0.00139	CcSEcCtD
Estradiol—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000156	0.00139	CcSEcCtD
Estradiol—Decreased appetite—Vincristine—muscle cancer	0.000156	0.00139	CcSEcCtD
Estradiol—Cough—Etoposide—muscle cancer	0.000155	0.00138	CcSEcCtD
Estradiol—Gastrointestinal disorder—Vincristine—muscle cancer	0.000155	0.00138	CcSEcCtD
Estradiol—Fatigue—Vincristine—muscle cancer	0.000155	0.00138	CcSEcCtD
Estradiol—Hypertension—Etoposide—muscle cancer	0.000154	0.00137	CcSEcCtD
Estradiol—Pain—Vincristine—muscle cancer	0.000153	0.00137	CcSEcCtD
Estradiol—Constipation—Vincristine—muscle cancer	0.000153	0.00137	CcSEcCtD
Estradiol—Osteoarthritis—Doxorubicin—muscle cancer	0.000153	0.00137	CcSEcCtD
Estradiol—Pain in extremity—Doxorubicin—muscle cancer	0.000153	0.00137	CcSEcCtD
Estradiol—Asthma—Methotrexate—muscle cancer	0.000153	0.00136	CcSEcCtD
Estradiol—Chest pain—Etoposide—muscle cancer	0.000151	0.00135	CcSEcCtD
Estradiol—Migraine—Doxorubicin—muscle cancer	0.000151	0.00134	CcSEcCtD
Estradiol—Affect lability—Doxorubicin—muscle cancer	0.000151	0.00134	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00015	0.00134	CcSEcCtD
Estradiol—Pancreatitis—Methotrexate—muscle cancer	0.00015	0.00134	CcSEcCtD
Estradiol—Discomfort—Etoposide—muscle cancer	0.00015	0.00133	CcSEcCtD
Estradiol—Face oedema—Doxorubicin—muscle cancer	0.000148	0.00132	CcSEcCtD
Estradiol—Hypersensitivity—Dactinomycin—muscle cancer	0.000148	0.00132	CcSEcCtD
Estradiol—Abdominal discomfort—Methotrexate—muscle cancer	0.000147	0.00131	CcSEcCtD
Estradiol—Gastrointestinal pain—Vincristine—muscle cancer	0.000147	0.00131	CcSEcCtD
Estradiol—Confusional state—Etoposide—muscle cancer	0.000146	0.0013	CcSEcCtD
Estradiol—Anaphylactic shock—Etoposide—muscle cancer	0.000145	0.00129	CcSEcCtD
Estradiol—Mood swings—Doxorubicin—muscle cancer	0.000145	0.00129	CcSEcCtD
Estradiol—Infection—Etoposide—muscle cancer	0.000144	0.00129	CcSEcCtD
Estradiol—Asthenia—Dactinomycin—muscle cancer	0.000144	0.00128	CcSEcCtD
Estradiol—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000142	0.00127	CcSEcCtD
Estradiol—Tachycardia—Etoposide—muscle cancer	0.000142	0.00126	CcSEcCtD
Estradiol—Abdominal pain—Vincristine—muscle cancer	0.000142	0.00126	CcSEcCtD
Estradiol—Body temperature increased—Vincristine—muscle cancer	0.000142	0.00126	CcSEcCtD
Estradiol—Liver function test abnormal—Doxorubicin—muscle cancer	0.000141	0.00126	CcSEcCtD
Estradiol—Skin disorder—Etoposide—muscle cancer	0.000141	0.00126	CcSEcCtD
Estradiol—Dry skin—Doxorubicin—muscle cancer	0.00014	0.00125	CcSEcCtD
Estradiol—Hyperhidrosis—Etoposide—muscle cancer	0.00014	0.00125	CcSEcCtD
Estradiol—Abdominal pain upper—Doxorubicin—muscle cancer	0.00014	0.00125	CcSEcCtD
Estradiol—Photosensitivity reaction—Methotrexate—muscle cancer	0.00014	0.00124	CcSEcCtD
Estradiol—ABCB1—bone marrow—muscle cancer	0.000139	0.00184	CbGeAlD
Estradiol—Breast disorder—Doxorubicin—muscle cancer	0.000138	0.00123	CcSEcCtD
Estradiol—Diarrhoea—Dactinomycin—muscle cancer	0.000137	0.00122	CcSEcCtD
Estradiol—Pneumonia—Methotrexate—muscle cancer	0.000137	0.00122	CcSEcCtD
Estradiol—Nasopharyngitis—Doxorubicin—muscle cancer	0.000137	0.00122	CcSEcCtD
Estradiol—Infestation NOS—Methotrexate—muscle cancer	0.000136	0.00122	CcSEcCtD
Estradiol—Infestation—Methotrexate—muscle cancer	0.000136	0.00122	CcSEcCtD
Estradiol—Depression—Methotrexate—muscle cancer	0.000136	0.00121	CcSEcCtD
Estradiol—Gastritis—Doxorubicin—muscle cancer	0.000136	0.00121	CcSEcCtD
Estradiol—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000135	0.0012	CcSEcCtD
Estradiol—CYP1A1—Melatonin metabolism and effects—FOXO1—muscle cancer	0.000135	0.00595	CbGpPWpGaD
Estradiol—Abdominal distension—Doxorubicin—muscle cancer	0.000133	0.00119	CcSEcCtD
Estradiol—ABCB1—vagina—muscle cancer	0.000133	0.00176	CbGeAlD
Estradiol—Conjunctivitis—Methotrexate—muscle cancer	0.000133	0.00118	CcSEcCtD
Estradiol—Asthma—Doxorubicin—muscle cancer	0.000132	0.00118	CcSEcCtD
Estradiol—Influenza—Doxorubicin—muscle cancer	0.000132	0.00118	CcSEcCtD
Estradiol—Dysphagia—Doxorubicin—muscle cancer	0.000132	0.00118	CcSEcCtD
Estradiol—Hypersensitivity—Vincristine—muscle cancer	0.000132	0.00118	CcSEcCtD
Estradiol—CYP3A5—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000132	0.00582	CbGpPWpGaD
Estradiol—Paraesthesia—Etoposide—muscle cancer	0.00013	0.00116	CcSEcCtD
Estradiol—Haematuria—Methotrexate—muscle cancer	0.00013	0.00116	CcSEcCtD
Estradiol—Pancreatitis—Doxorubicin—muscle cancer	0.00013	0.00116	CcSEcCtD
Estradiol—Dyspnoea—Etoposide—muscle cancer	0.000129	0.00115	CcSEcCtD
Estradiol—Somnolence—Etoposide—muscle cancer	0.000129	0.00115	CcSEcCtD
Estradiol—Hepatobiliary disease—Methotrexate—muscle cancer	0.000129	0.00115	CcSEcCtD
Estradiol—Epistaxis—Methotrexate—muscle cancer	0.000129	0.00115	CcSEcCtD
Estradiol—Asthenia—Vincristine—muscle cancer	0.000129	0.00115	CcSEcCtD
Estradiol—Vomiting—Dactinomycin—muscle cancer	0.000128	0.00114	CcSEcCtD
Estradiol—Bronchitis—Doxorubicin—muscle cancer	0.000127	0.00114	CcSEcCtD
Estradiol—ESRRA—Generic Transcription Pathway—MED12—muscle cancer	0.000127	0.00561	CbGpPWpGaD
Estradiol—Rash—Dactinomycin—muscle cancer	0.000127	0.00113	CcSEcCtD
Estradiol—Decreased appetite—Etoposide—muscle cancer	0.000126	0.00112	CcSEcCtD
Estradiol—Gastrointestinal disorder—Etoposide—muscle cancer	0.000125	0.00112	CcSEcCtD
Estradiol—Fatigue—Etoposide—muscle cancer	0.000125	0.00112	CcSEcCtD
Estradiol—Pain—Etoposide—muscle cancer	0.000124	0.00111	CcSEcCtD
Estradiol—Constipation—Etoposide—muscle cancer	0.000124	0.00111	CcSEcCtD
Estradiol—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000123	0.0011	CcSEcCtD
Estradiol—Haemoglobin—Methotrexate—muscle cancer	0.000123	0.0011	CcSEcCtD
Estradiol—ABCB1—head—muscle cancer	0.000123	0.00163	CbGeAlD
Estradiol—Diarrhoea—Vincristine—muscle cancer	0.000123	0.00109	CcSEcCtD
Estradiol—Hepatitis—Methotrexate—muscle cancer	0.000122	0.00109	CcSEcCtD
Estradiol—Haemorrhage—Methotrexate—muscle cancer	0.000122	0.00109	CcSEcCtD
Estradiol—Pollakiuria—Doxorubicin—muscle cancer	0.000122	0.00109	CcSEcCtD
Estradiol—Pharyngitis—Methotrexate—muscle cancer	0.000122	0.00108	CcSEcCtD
Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO4—muscle cancer	0.000121	0.00535	CbGpPWpGaD
Estradiol—Urinary tract disorder—Methotrexate—muscle cancer	0.000121	0.00108	CcSEcCtD
Estradiol—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000121	0.00108	CcSEcCtD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.000121	0.00534	CbGpPWpGaD
Estradiol—Weight increased—Doxorubicin—muscle cancer	0.000121	0.00107	CcSEcCtD
Estradiol—Urethral disorder—Methotrexate—muscle cancer	0.00012	0.00107	CcSEcCtD
Estradiol—Weight decreased—Doxorubicin—muscle cancer	0.00012	0.00107	CcSEcCtD
Estradiol—Feeling abnormal—Etoposide—muscle cancer	0.00012	0.00107	CcSEcCtD
Estradiol—Hyperglycaemia—Doxorubicin—muscle cancer	0.000119	0.00106	CcSEcCtD
Estradiol—Nausea—Dactinomycin—muscle cancer	0.000119	0.00106	CcSEcCtD
Estradiol—ABCB1—testis—muscle cancer	0.000119	0.00157	CbGeAlD
Estradiol—Pneumonia—Doxorubicin—muscle cancer	0.000119	0.00106	CcSEcCtD
Estradiol—Gastrointestinal pain—Etoposide—muscle cancer	0.000119	0.00106	CcSEcCtD
Estradiol—Dizziness—Vincristine—muscle cancer	0.000119	0.00106	CcSEcCtD
Estradiol—Infestation NOS—Doxorubicin—muscle cancer	0.000118	0.00105	CcSEcCtD
Estradiol—Infestation—Doxorubicin—muscle cancer	0.000118	0.00105	CcSEcCtD
Estradiol—Visual impairment—Methotrexate—muscle cancer	0.000118	0.00105	CcSEcCtD
Estradiol—AR—Regulation of nuclear SMAD2/3 signaling—FOXO1—muscle cancer	0.000116	0.00513	CbGpPWpGaD
Estradiol—Erythema multiforme—Methotrexate—muscle cancer	0.000116	0.00103	CcSEcCtD
Estradiol—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000116	0.00103	CcSEcCtD
Estradiol—Urticaria—Etoposide—muscle cancer	0.000115	0.00103	CcSEcCtD
Estradiol—Jaundice—Doxorubicin—muscle cancer	0.000115	0.00103	CcSEcCtD
Estradiol—Body temperature increased—Etoposide—muscle cancer	0.000115	0.00102	CcSEcCtD
Estradiol—Abdominal pain—Etoposide—muscle cancer	0.000115	0.00102	CcSEcCtD
Estradiol—Conjunctivitis—Doxorubicin—muscle cancer	0.000115	0.00102	CcSEcCtD
Estradiol—Urinary tract infection—Doxorubicin—muscle cancer	0.000115	0.00102	CcSEcCtD
Estradiol—NR1I2—Generic Transcription Pathway—MED12—muscle cancer	0.000115	0.00507	CbGpPWpGaD
Estradiol—Eye disorder—Methotrexate—muscle cancer	0.000114	0.00102	CcSEcCtD
Estradiol—Tinnitus—Methotrexate—muscle cancer	0.000114	0.00102	CcSEcCtD
Estradiol—Vomiting—Vincristine—muscle cancer	0.000114	0.00102	CcSEcCtD
Estradiol—Cardiac disorder—Methotrexate—muscle cancer	0.000114	0.00101	CcSEcCtD
Estradiol—Rash—Vincristine—muscle cancer	0.000113	0.00101	CcSEcCtD
Estradiol—Dermatitis—Vincristine—muscle cancer	0.000113	0.00101	CcSEcCtD
Estradiol—Haematuria—Doxorubicin—muscle cancer	0.000113	0.001	CcSEcCtD
Estradiol—Headache—Vincristine—muscle cancer	0.000112	0.001	CcSEcCtD
Estradiol—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000112	0.000995	CcSEcCtD
Estradiol—Epistaxis—Doxorubicin—muscle cancer	0.000111	0.000993	CcSEcCtD
Estradiol—Angiopathy—Methotrexate—muscle cancer	0.000111	0.00099	CcSEcCtD
Estradiol—Sinusitis—Doxorubicin—muscle cancer	0.000111	0.000987	CcSEcCtD
Estradiol—Immune system disorder—Methotrexate—muscle cancer	0.000111	0.000985	CcSEcCtD
Estradiol—Mediastinal disorder—Methotrexate—muscle cancer	0.00011	0.000983	CcSEcCtD
Estradiol—CYP2C19—Melatonin metabolism and effects—FOXO1—muscle cancer	0.00011	0.00487	CbGpPWpGaD
Estradiol—Chills—Methotrexate—muscle cancer	0.00011	0.000979	CcSEcCtD
Estradiol—Alopecia—Methotrexate—muscle cancer	0.000108	0.000964	CcSEcCtD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000108	0.00478	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—PTCH1—muscle cancer	0.000108	0.00476	CbGpPWpGaD
Estradiol—AR—Androgen receptor signaling pathway—FOXO1—muscle cancer	0.000108	0.00476	CbGpPWpGaD
Estradiol—Mental disorder—Methotrexate—muscle cancer	0.000107	0.000956	CcSEcCtD
Estradiol—Hypersensitivity—Etoposide—muscle cancer	0.000107	0.000953	CcSEcCtD
Estradiol—ESRRA—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000107	0.00471	CbGpPWpGaD
Estradiol—Erythema—Methotrexate—muscle cancer	0.000107	0.00095	CcSEcCtD
Estradiol—Malnutrition—Methotrexate—muscle cancer	0.000107	0.00095	CcSEcCtD
Estradiol—Haemoglobin—Doxorubicin—muscle cancer	0.000107	0.000949	CcSEcCtD
Estradiol—Nausea—Vincristine—muscle cancer	0.000106	0.000949	CcSEcCtD
Estradiol—Rhinitis—Doxorubicin—muscle cancer	0.000106	0.000947	CcSEcCtD
Estradiol—Hepatitis—Doxorubicin—muscle cancer	0.000106	0.000945	CcSEcCtD
Estradiol—Haemorrhage—Doxorubicin—muscle cancer	0.000106	0.000945	CcSEcCtD
Estradiol—Hypoaesthesia—Doxorubicin—muscle cancer	0.000105	0.00094	CcSEcCtD
Estradiol—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—muscle cancer	0.000105	0.00466	CbGpPWpGaD
Estradiol—Pharyngitis—Doxorubicin—muscle cancer	0.000105	0.000938	CcSEcCtD
Estradiol—Urinary tract disorder—Doxorubicin—muscle cancer	0.000105	0.000933	CcSEcCtD
Estradiol—Oedema peripheral—Doxorubicin—muscle cancer	0.000104	0.000931	CcSEcCtD
Estradiol—Dysgeusia—Methotrexate—muscle cancer	0.000104	0.00093	CcSEcCtD
Estradiol—Asthenia—Etoposide—muscle cancer	0.000104	0.000928	CcSEcCtD
Estradiol—Connective tissue disorder—Doxorubicin—muscle cancer	0.000104	0.000928	CcSEcCtD
Estradiol—Urethral disorder—Doxorubicin—muscle cancer	0.000104	0.000926	CcSEcCtD
Estradiol—Back pain—Methotrexate—muscle cancer	0.000103	0.000919	CcSEcCtD
Estradiol—Pruritus—Etoposide—muscle cancer	0.000103	0.000915	CcSEcCtD
Estradiol—Visual impairment—Doxorubicin—muscle cancer	0.000102	0.00091	CcSEcCtD
Estradiol—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000102	0.0045	CbGpPWpGaD
Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—muscle cancer	0.000101	0.00447	CbGpPWpGaD
Estradiol—Erythema multiforme—Doxorubicin—muscle cancer	0.0001	0.000893	CcSEcCtD
Estradiol—GPER1—GPCR downstream signaling—CNR1—muscle cancer	0.0001	0.00442	CbGpPWpGaD
Estradiol—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	9.96e-05	0.0044	CbGpPWpGaD
Estradiol—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	9.94e-05	0.00439	CbGpPWpGaD
Estradiol—Diarrhoea—Etoposide—muscle cancer	9.94e-05	0.000885	CcSEcCtD
Estradiol—Eye disorder—Doxorubicin—muscle cancer	9.91e-05	0.000883	CcSEcCtD
Estradiol—Ill-defined disorder—Methotrexate—muscle cancer	9.89e-05	0.000881	CcSEcCtD
Estradiol—Tinnitus—Doxorubicin—muscle cancer	9.88e-05	0.000881	CcSEcCtD
Estradiol—Flushing—Doxorubicin—muscle cancer	9.84e-05	0.000877	CcSEcCtD
Estradiol—Cardiac disorder—Doxorubicin—muscle cancer	9.84e-05	0.000877	CcSEcCtD
Estradiol—AR—Regulation of Androgen receptor activity—MDM2—muscle cancer	9.77e-05	0.00432	CbGpPWpGaD
Estradiol—Angiopathy—Doxorubicin—muscle cancer	9.62e-05	0.000857	CcSEcCtD
Estradiol—Malaise—Methotrexate—muscle cancer	9.61e-05	0.000856	CcSEcCtD
Estradiol—Dizziness—Etoposide—muscle cancer	9.6e-05	0.000856	CcSEcCtD
Estradiol—Immune system disorder—Doxorubicin—muscle cancer	9.58e-05	0.000853	CcSEcCtD
Estradiol—Vertigo—Methotrexate—muscle cancer	9.57e-05	0.000853	CcSEcCtD
Estradiol—Mediastinal disorder—Doxorubicin—muscle cancer	9.55e-05	0.000851	CcSEcCtD
Estradiol—Chills—Doxorubicin—muscle cancer	9.51e-05	0.000848	CcSEcCtD
Estradiol—ESR1—Leptin signaling pathway—FOXO1—muscle cancer	9.5e-05	0.0042	CbGpPWpGaD
Estradiol—Alopecia—Doxorubicin—muscle cancer	9.37e-05	0.000835	CcSEcCtD
Estradiol—ESR1—FOXM1 transcription factor network—CDKN2A—muscle cancer	9.35e-05	0.00413	CbGpPWpGaD
Estradiol—Cough—Methotrexate—muscle cancer	9.3e-05	0.000829	CcSEcCtD
Estradiol—Mental disorder—Doxorubicin—muscle cancer	9.29e-05	0.000828	CcSEcCtD
Estradiol—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	9.29e-05	0.0041	CbGpPWpGaD
Estradiol—Vomiting—Etoposide—muscle cancer	9.23e-05	0.000823	CcSEcCtD
Estradiol—Malnutrition—Doxorubicin—muscle cancer	9.23e-05	0.000822	CcSEcCtD
Estradiol—Erythema—Doxorubicin—muscle cancer	9.23e-05	0.000822	CcSEcCtD
Estradiol—Rash—Etoposide—muscle cancer	9.16e-05	0.000816	CcSEcCtD
Estradiol—Dermatitis—Etoposide—muscle cancer	9.15e-05	0.000815	CcSEcCtD
Estradiol—Headache—Etoposide—muscle cancer	9.1e-05	0.000811	CcSEcCtD
Estradiol—Flatulence—Doxorubicin—muscle cancer	9.09e-05	0.00081	CcSEcCtD
Estradiol—GPER1—Signaling by GPCR—CNR1—muscle cancer	9.08e-05	0.00401	CbGpPWpGaD
Estradiol—Myalgia—Methotrexate—muscle cancer	9.07e-05	0.000809	CcSEcCtD
Estradiol—Arthralgia—Methotrexate—muscle cancer	9.07e-05	0.000809	CcSEcCtD
Estradiol—Chest pain—Methotrexate—muscle cancer	9.07e-05	0.000809	CcSEcCtD
Estradiol—CYP1B1—Tryptophan metabolism—MDM2—muscle cancer	9.07e-05	0.00401	CbGpPWpGaD
Estradiol—Tension—Doxorubicin—muscle cancer	9.06e-05	0.000807	CcSEcCtD
Estradiol—Dysgeusia—Doxorubicin—muscle cancer	9.04e-05	0.000805	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	9.01e-05	0.000803	CcSEcCtD
Estradiol—AR—Coregulation of Androgen receptor activity—CDKN2A—muscle cancer	9.01e-05	0.00398	CbGpPWpGaD
Estradiol—Discomfort—Methotrexate—muscle cancer	8.96e-05	0.000799	CcSEcCtD
Estradiol—Nervousness—Doxorubicin—muscle cancer	8.96e-05	0.000799	CcSEcCtD
Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO1—muscle cancer	8.94e-05	0.00395	CbGpPWpGaD
Estradiol—Back pain—Doxorubicin—muscle cancer	8.93e-05	0.000795	CcSEcCtD
Estradiol—Muscle spasms—Doxorubicin—muscle cancer	8.87e-05	0.000791	CcSEcCtD
Estradiol—Confusional state—Methotrexate—muscle cancer	8.77e-05	0.000782	CcSEcCtD
Estradiol—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	8.75e-05	0.00386	CbGpPWpGaD
Estradiol—Anaphylactic shock—Methotrexate—muscle cancer	8.7e-05	0.000775	CcSEcCtD
Estradiol—Infection—Methotrexate—muscle cancer	8.64e-05	0.00077	CcSEcCtD
Estradiol—Nausea—Etoposide—muscle cancer	8.63e-05	0.000769	CcSEcCtD
Estradiol—CYP1A2—Melatonin metabolism and effects—FOXO1—muscle cancer	8.59e-05	0.00379	CbGpPWpGaD
Estradiol—Ill-defined disorder—Doxorubicin—muscle cancer	8.56e-05	0.000763	CcSEcCtD
Estradiol—Nervous system disorder—Methotrexate—muscle cancer	8.53e-05	0.00076	CcSEcCtD
Estradiol—Agitation—Doxorubicin—muscle cancer	8.48e-05	0.000756	CcSEcCtD
Estradiol—Skin disorder—Methotrexate—muscle cancer	8.45e-05	0.000753	CcSEcCtD
Estradiol—CYP1A1—PPARA activates gene expression—MED12—muscle cancer	8.44e-05	0.00373	CbGpPWpGaD
Estradiol—Hyperhidrosis—Methotrexate—muscle cancer	8.41e-05	0.000749	CcSEcCtD
Estradiol—ESRRA—Metabolism—FH—muscle cancer	8.41e-05	0.00372	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	8.33e-05	0.00368	CbGpPWpGaD
Estradiol—Malaise—Doxorubicin—muscle cancer	8.32e-05	0.000742	CcSEcCtD
Estradiol—Vertigo—Doxorubicin—muscle cancer	8.29e-05	0.000739	CcSEcCtD
Estradiol—Syncope—Doxorubicin—muscle cancer	8.28e-05	0.000737	CcSEcCtD
Estradiol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	8.26e-05	0.00365	CbGpPWpGaD
Estradiol—CYP1B1—Arachidonic acid metabolism—PTGS2—muscle cancer	8.18e-05	0.00362	CbGpPWpGaD
Estradiol—Palpitations—Doxorubicin—muscle cancer	8.16e-05	0.000727	CcSEcCtD
Estradiol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	8.13e-05	0.00359	CbGpPWpGaD
Estradiol—Loss of consciousness—Doxorubicin—muscle cancer	8.11e-05	0.000723	CcSEcCtD
Estradiol—ESR2—Generic Transcription Pathway—MED12—muscle cancer	8.08e-05	0.00357	CbGpPWpGaD
Estradiol—Cough—Doxorubicin—muscle cancer	8.05e-05	0.000718	CcSEcCtD
Estradiol—ABCG2—HIF-2-alpha transcription factor network—VEGFA—muscle cancer	7.98e-05	0.00353	CbGpPWpGaD
Estradiol—Hypertension—Doxorubicin—muscle cancer	7.97e-05	0.00071	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Methotrexate—muscle cancer	7.92e-05	0.000706	CcSEcCtD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	7.91e-05	0.0035	CbGpPWpGaD
Estradiol—Insomnia—Methotrexate—muscle cancer	7.87e-05	0.000701	CcSEcCtD
Estradiol—Arthralgia—Doxorubicin—muscle cancer	7.86e-05	0.0007	CcSEcCtD
Estradiol—Chest pain—Doxorubicin—muscle cancer	7.86e-05	0.0007	CcSEcCtD
Estradiol—Myalgia—Doxorubicin—muscle cancer	7.86e-05	0.0007	CcSEcCtD
Estradiol—Anxiety—Doxorubicin—muscle cancer	7.83e-05	0.000698	CcSEcCtD
Estradiol—Paraesthesia—Methotrexate—muscle cancer	7.81e-05	0.000696	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	7.8e-05	0.000695	CcSEcCtD
Estradiol—Discomfort—Doxorubicin—muscle cancer	7.76e-05	0.000692	CcSEcCtD
Estradiol—Dyspnoea—Methotrexate—muscle cancer	7.75e-05	0.000691	CcSEcCtD
Estradiol—Somnolence—Methotrexate—muscle cancer	7.73e-05	0.000689	CcSEcCtD
Estradiol—Dry mouth—Doxorubicin—muscle cancer	7.68e-05	0.000685	CcSEcCtD
Estradiol—Dyspepsia—Methotrexate—muscle cancer	7.66e-05	0.000682	CcSEcCtD
Estradiol—Confusional state—Doxorubicin—muscle cancer	7.59e-05	0.000677	CcSEcCtD
Estradiol—Decreased appetite—Methotrexate—muscle cancer	7.56e-05	0.000674	CcSEcCtD
Estradiol—Anaphylactic shock—Doxorubicin—muscle cancer	7.53e-05	0.000671	CcSEcCtD
Estradiol—Oedema—Doxorubicin—muscle cancer	7.53e-05	0.000671	CcSEcCtD
Estradiol—Gastrointestinal disorder—Methotrexate—muscle cancer	7.51e-05	0.000669	CcSEcCtD
Estradiol—Fatigue—Methotrexate—muscle cancer	7.5e-05	0.000668	CcSEcCtD
Estradiol—Infection—Doxorubicin—muscle cancer	7.48e-05	0.000667	CcSEcCtD
Estradiol—Pain—Methotrexate—muscle cancer	7.44e-05	0.000663	CcSEcCtD
Estradiol—Shock—Doxorubicin—muscle cancer	7.41e-05	0.00066	CcSEcCtD
Estradiol—Nervous system disorder—Doxorubicin—muscle cancer	7.39e-05	0.000658	CcSEcCtD
Estradiol—Tachycardia—Doxorubicin—muscle cancer	7.35e-05	0.000655	CcSEcCtD
Estradiol—Skin disorder—Doxorubicin—muscle cancer	7.32e-05	0.000652	CcSEcCtD
Estradiol—ESR1—Signaling by ERBB4—FOXO4—muscle cancer	7.31e-05	0.00323	CbGpPWpGaD
Estradiol—Hyperhidrosis—Doxorubicin—muscle cancer	7.28e-05	0.000649	CcSEcCtD
Estradiol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—muscle cancer	7.25e-05	0.0032	CbGpPWpGaD
Estradiol—Feeling abnormal—Methotrexate—muscle cancer	7.17e-05	0.000639	CcSEcCtD
Estradiol—Gastrointestinal pain—Methotrexate—muscle cancer	7.11e-05	0.000634	CcSEcCtD
Estradiol—AR—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	7.05e-05	0.00312	CbGpPWpGaD
Estradiol—Urticaria—Methotrexate—muscle cancer	6.91e-05	0.000616	CcSEcCtD
Estradiol—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	6.89e-05	0.00304	CbGpPWpGaD
Estradiol—Abdominal pain—Methotrexate—muscle cancer	6.88e-05	0.000613	CcSEcCtD
Estradiol—Body temperature increased—Methotrexate—muscle cancer	6.88e-05	0.000613	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Doxorubicin—muscle cancer	6.86e-05	0.000611	CcSEcCtD
Estradiol—Insomnia—Doxorubicin—muscle cancer	6.81e-05	0.000607	CcSEcCtD
Estradiol—Paraesthesia—Doxorubicin—muscle cancer	6.76e-05	0.000603	CcSEcCtD
Estradiol—Dyspnoea—Doxorubicin—muscle cancer	6.71e-05	0.000598	CcSEcCtD
Estradiol—Somnolence—Doxorubicin—muscle cancer	6.7e-05	0.000597	CcSEcCtD
Estradiol—Dyspepsia—Doxorubicin—muscle cancer	6.63e-05	0.000591	CcSEcCtD
Estradiol—Decreased appetite—Doxorubicin—muscle cancer	6.55e-05	0.000583	CcSEcCtD
Estradiol—Gastrointestinal disorder—Doxorubicin—muscle cancer	6.5e-05	0.000579	CcSEcCtD
Estradiol—Fatigue—Doxorubicin—muscle cancer	6.49e-05	0.000579	CcSEcCtD
Estradiol—AR—Androgen receptor signaling pathway—MDM2—muscle cancer	6.46e-05	0.00285	CbGpPWpGaD
Estradiol—Constipation—Doxorubicin—muscle cancer	6.44e-05	0.000574	CcSEcCtD
Estradiol—Pain—Doxorubicin—muscle cancer	6.44e-05	0.000574	CcSEcCtD
Estradiol—Hypersensitivity—Methotrexate—muscle cancer	6.41e-05	0.000571	CcSEcCtD
Estradiol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	6.4e-05	0.00283	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—PTCH1—muscle cancer	6.36e-05	0.00281	CbGpPWpGaD
Estradiol—Asthenia—Methotrexate—muscle cancer	6.24e-05	0.000556	CcSEcCtD
Estradiol—ESR1—AP-1 transcription factor network—CDKN2A—muscle cancer	6.21e-05	0.00275	CbGpPWpGaD
Estradiol—Feeling abnormal—Doxorubicin—muscle cancer	6.21e-05	0.000553	CcSEcCtD
Estradiol—ABCG2—Fluoropyrimidine Activity—TP53—muscle cancer	6.18e-05	0.00273	CbGpPWpGaD
Estradiol—Gastrointestinal pain—Doxorubicin—muscle cancer	6.16e-05	0.000549	CcSEcCtD
Estradiol—Pruritus—Methotrexate—muscle cancer	6.15e-05	0.000548	CcSEcCtD
Estradiol—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	6.12e-05	0.00271	CbGpPWpGaD
Estradiol—ESRRA—Gene Expression—MED12—muscle cancer	6.11e-05	0.0027	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	6.09e-05	0.00269	CbGpPWpGaD
Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—muscle cancer	6.02e-05	0.00266	CbGpPWpGaD
Estradiol—Urticaria—Doxorubicin—muscle cancer	5.98e-05	0.000533	CcSEcCtD
Estradiol—Abdominal pain—Doxorubicin—muscle cancer	5.95e-05	0.000531	CcSEcCtD
Estradiol—Body temperature increased—Doxorubicin—muscle cancer	5.95e-05	0.000531	CcSEcCtD
Estradiol—Diarrhoea—Methotrexate—muscle cancer	5.95e-05	0.00053	CcSEcCtD
Estradiol—ALB—Platelet degranulation—IGF2—muscle cancer	5.92e-05	0.00262	CbGpPWpGaD
Estradiol—AOX1—Metabolism—FH—muscle cancer	5.83e-05	0.00258	CbGpPWpGaD
Estradiol—Dizziness—Methotrexate—muscle cancer	5.75e-05	0.000513	CcSEcCtD
Estradiol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	5.69e-05	0.00252	CbGpPWpGaD
Estradiol—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	5.64e-05	0.00249	CbGpPWpGaD
Estradiol—CYP1A1—Tryptophan metabolism—MDM2—muscle cancer	5.59e-05	0.00247	CbGpPWpGaD
Estradiol—Hypersensitivity—Doxorubicin—muscle cancer	5.55e-05	0.000494	CcSEcCtD
Estradiol—Vomiting—Methotrexate—muscle cancer	5.53e-05	0.000493	CcSEcCtD
Estradiol—NR1I2—Gene Expression—MED12—muscle cancer	5.53e-05	0.00244	CbGpPWpGaD
Estradiol—Rash—Methotrexate—muscle cancer	5.48e-05	0.000489	CcSEcCtD
Estradiol—Dermatitis—Methotrexate—muscle cancer	5.48e-05	0.000488	CcSEcCtD
Estradiol—GPER1—Signaling Pathways—FOXO4—muscle cancer	5.47e-05	0.00242	CbGpPWpGaD
Estradiol—Headache—Methotrexate—muscle cancer	5.45e-05	0.000486	CcSEcCtD
Estradiol—ESR1—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	5.43e-05	0.0024	CbGpPWpGaD
Estradiol—Asthenia—Doxorubicin—muscle cancer	5.4e-05	0.000482	CcSEcCtD
Estradiol—ESR1—Signaling by ERBB4—FOXO1—muscle cancer	5.4e-05	0.00239	CbGpPWpGaD
Estradiol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	5.39e-05	0.00238	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	5.39e-05	0.00238	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.38e-05	0.00238	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—CNR1—muscle cancer	5.37e-05	0.00237	CbGpPWpGaD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	5.35e-05	0.00237	CbGpPWpGaD
Estradiol—Pruritus—Doxorubicin—muscle cancer	5.33e-05	0.000475	CcSEcCtD
Estradiol—AR—Generic Transcription Pathway—MED12—muscle cancer	5.29e-05	0.00234	CbGpPWpGaD
Estradiol—Nausea—Methotrexate—muscle cancer	5.17e-05	0.00046	CcSEcCtD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	5.16e-05	0.00228	CbGpPWpGaD
Estradiol—Diarrhoea—Doxorubicin—muscle cancer	5.15e-05	0.000459	CcSEcCtD
Estradiol—ESR1—LKB1 signaling events—TP53—muscle cancer	5.11e-05	0.00226	CbGpPWpGaD
Estradiol—CYP1A1—Arachidonic acid metabolism—PTGS2—muscle cancer	5.04e-05	0.00223	CbGpPWpGaD
Estradiol—Dizziness—Doxorubicin—muscle cancer	4.98e-05	0.000444	CcSEcCtD
Estradiol—Vomiting—Doxorubicin—muscle cancer	4.79e-05	0.000427	CcSEcCtD
Estradiol—ESR2—SIDS Susceptibility Pathways—VEGFA—muscle cancer	4.78e-05	0.00211	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—MED12—muscle cancer	4.75e-05	0.0021	CbGpPWpGaD
Estradiol—Rash—Doxorubicin—muscle cancer	4.75e-05	0.000423	CcSEcCtD
Estradiol—Dermatitis—Doxorubicin—muscle cancer	4.74e-05	0.000423	CcSEcCtD
Estradiol—Headache—Doxorubicin—muscle cancer	4.72e-05	0.00042	CcSEcCtD
Estradiol—ABCG2—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	4.7e-05	0.00207	CbGpPWpGaD
Estradiol—CYP2C8—Arachidonic acid metabolism—PTGS2—muscle cancer	4.62e-05	0.00204	CbGpPWpGaD
Estradiol—Nausea—Doxorubicin—muscle cancer	4.47e-05	0.000399	CcSEcCtD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	4.41e-05	0.00195	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—IGF2—muscle cancer	4.39e-05	0.00194	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—ENO2—muscle cancer	4.33e-05	0.00191	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—FH—muscle cancer	4.24e-05	0.00188	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	4.24e-05	0.00187	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	4.23e-05	0.00187	CbGpPWpGaD
Estradiol—AR—Integrated Breast Cancer Pathway—MDM2—muscle cancer	4.23e-05	0.00187	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—FH—muscle cancer	4.17e-05	0.00184	CbGpPWpGaD
Estradiol—CYP2C19—Arachidonic acid metabolism—PTGS2—muscle cancer	4.12e-05	0.00182	CbGpPWpGaD
Estradiol—ESR1—Signaling by ERBB4—KIT—muscle cancer	4.12e-05	0.00182	CbGpPWpGaD
Estradiol—ESR1—Generic Transcription Pathway—MED12—muscle cancer	4.07e-05	0.0018	CbGpPWpGaD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	4.07e-05	0.0018	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—FOXO1—muscle cancer	4.04e-05	0.00178	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—MED12—muscle cancer	3.89e-05	0.00172	CbGpPWpGaD
Estradiol—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	3.76e-05	0.00166	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.68e-05	0.00163	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.62e-05	0.0016	CbGpPWpGaD
Estradiol—AOX1—Disease—ENO2—muscle cancer	3.58e-05	0.00158	CbGpPWpGaD
Estradiol—CYP1A2—Tryptophan metabolism—MDM2—muscle cancer	3.56e-05	0.00157	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	3.51e-05	0.00155	CbGpPWpGaD
Estradiol—ESR1—AP-1 transcription factor network—TP53—muscle cancer	3.46e-05	0.00153	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	3.43e-05	0.00152	CbGpPWpGaD
Estradiol—ESRRA—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.39e-05	0.0015	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	3.38e-05	0.00149	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—FH—muscle cancer	3.33e-05	0.00147	CbGpPWpGaD
Estradiol—AOX1—Metabolism—MED12—muscle cancer	3.29e-05	0.00146	CbGpPWpGaD
Estradiol—ESR1—Integrated Breast Cancer Pathway—MDM2—muscle cancer	3.26e-05	0.00144	CbGpPWpGaD
Estradiol—AOX1—Disease—HMGA1—muscle cancer	3.26e-05	0.00144	CbGpPWpGaD
Estradiol—ESR1—Signaling by ERBB4—MDM2—muscle cancer	3.24e-05	0.00143	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	3.22e-05	0.00142	CbGpPWpGaD
Estradiol—CYP1A2—Arachidonic acid metabolism—PTGS2—muscle cancer	3.21e-05	0.00142	CbGpPWpGaD
Estradiol—AR—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	3.21e-05	0.00142	CbGpPWpGaD
Estradiol—AR—SIDS Susceptibility Pathways—VEGFA—muscle cancer	3.13e-05	0.00138	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—FH—muscle cancer	3.11e-05	0.00138	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—KIT—muscle cancer	3.08e-05	0.00136	CbGpPWpGaD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	3.07e-05	0.00136	CbGpPWpGaD
Estradiol—AOX1—Metabolism—ENO2—muscle cancer	3e-05	0.00133	CbGpPWpGaD
Estradiol—AOX1—Disease—FOXO4—muscle cancer	2.92e-05	0.00129	CbGpPWpGaD
Estradiol—ALB—Selenium Micronutrient Network—PTGS2—muscle cancer	2.92e-05	0.00129	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—FH—muscle cancer	2.9e-05	0.00128	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—FH—muscle cancer	2.85e-05	0.00126	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KIDINS220—muscle cancer	2.8e-05	0.00124	CbGpPWpGaD
Estradiol—ALB—Hemostasis—ANGPT2—muscle cancer	2.79e-05	0.00123	CbGpPWpGaD
Estradiol—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	2.75e-05	0.00121	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	2.7e-05	0.0012	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	2.7e-05	0.00119	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	2.66e-05	0.00118	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—FH—muscle cancer	2.64e-05	0.00117	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—IGF2—muscle cancer	2.63e-05	0.00116	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—FH—muscle cancer	2.62e-05	0.00116	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—FH—muscle cancer	2.61e-05	0.00115	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	2.6e-05	0.00115	CbGpPWpGaD
Estradiol—AR—Gene Expression—MED12—muscle cancer	2.55e-05	0.00112	CbGpPWpGaD
Estradiol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	2.54e-05	0.00112	CbGpPWpGaD
Estradiol—SLC22A2—Transmission across Chemical Synapses—MDM2—muscle cancer	2.52e-05	0.00111	CbGpPWpGaD
Estradiol—ALB—Platelet degranulation—VEGFA—muscle cancer	2.48e-05	0.0011	CbGpPWpGaD
Estradiol—ESR1—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	2.47e-05	0.00109	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—FH—muscle cancer	2.44e-05	0.00108	CbGpPWpGaD
Estradiol—AR—Integrated Breast Cancer Pathway—TP53—muscle cancer	2.43e-05	0.00107	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—MDM2—muscle cancer	2.42e-05	0.00107	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—MED12—muscle cancer	2.4e-05	0.00106	CbGpPWpGaD
Estradiol—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	2.37e-05	0.00105	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—MED12—muscle cancer	2.35e-05	0.00104	CbGpPWpGaD
Estradiol—SLC22A1—Transmission across Chemical Synapses—MDM2—muscle cancer	2.35e-05	0.00104	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.27e-05	0.001	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—VEGFA—muscle cancer	2.2e-05	0.000972	CbGpPWpGaD
Estradiol—ALB—Folate Metabolism—TP53—muscle cancer	2.19e-05	0.000967	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—ENO2—muscle cancer	2.19e-05	0.000966	CbGpPWpGaD
Estradiol—AOX1—Disease—FOXO1—muscle cancer	2.16e-05	0.000954	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—ENO2—muscle cancer	2.15e-05	0.000948	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.08e-05	0.000919	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.07e-05	0.000913	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	2.05e-05	0.000906	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	2.01e-05	0.000889	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—MED12—muscle cancer	1.96e-05	0.000866	CbGpPWpGaD
Estradiol—SLC22A2—Neuronal System—MDM2—muscle cancer	1.93e-05	0.000853	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—FH—muscle cancer	1.89e-05	0.000836	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—MED12—muscle cancer	1.88e-05	0.000833	CbGpPWpGaD
Estradiol—ESR1—Integrated Breast Cancer Pathway—TP53—muscle cancer	1.87e-05	0.000826	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.86e-05	0.00082	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—VEGFA—muscle cancer	1.84e-05	0.000813	CbGpPWpGaD
Estradiol—SLC22A1—Neuronal System—MDM2—muscle cancer	1.8e-05	0.000795	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—FH—muscle cancer	1.79e-05	0.00079	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—MED12—muscle cancer	1.76e-05	0.000777	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—ENO2—muscle cancer	1.72e-05	0.000759	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.71e-05	0.000756	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.69e-05	0.000748	CbGpPWpGaD
Estradiol—AOX1—Disease—KIT—muscle cancer	1.64e-05	0.000727	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—MED12—muscle cancer	1.64e-05	0.000725	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—FH—muscle cancer	1.64e-05	0.000724	CbGpPWpGaD
Estradiol—ALB—Metabolism—FH—muscle cancer	1.63e-05	0.00072	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—MED12—muscle cancer	1.61e-05	0.000712	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—ENO2—muscle cancer	1.6e-05	0.000708	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	1.55e-05	0.000685	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—PTGS2—muscle cancer	1.51e-05	0.000667	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—ENO2—muscle cancer	1.5e-05	0.000661	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—MED12—muscle cancer	1.49e-05	0.000659	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—MED12—muscle cancer	1.48e-05	0.000653	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—MED12—muscle cancer	1.48e-05	0.000652	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—ENO2—muscle cancer	1.47e-05	0.000649	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—FH—muscle cancer	1.46e-05	0.000646	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.45e-05	0.000639	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	1.43e-05	0.000631	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—FH—muscle cancer	1.43e-05	0.000631	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—TP53—muscle cancer	1.39e-05	0.000614	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	1.38e-05	0.000609	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—MED12—muscle cancer	1.38e-05	0.000608	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—ENO2—muscle cancer	1.36e-05	0.000601	CbGpPWpGaD
Estradiol—ALB—Hemostasis—IGF2—muscle cancer	1.35e-05	0.000598	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—ENO2—muscle cancer	1.35e-05	0.000596	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—ENO2—muscle cancer	1.35e-05	0.000595	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.34e-05	0.000594	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—FH—muscle cancer	1.33e-05	0.000589	CbGpPWpGaD
Estradiol—AOX1—Disease—MDM2—muscle cancer	1.3e-05	0.000572	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—ENO2—muscle cancer	1.25e-05	0.000554	CbGpPWpGaD
Estradiol—AOX1—Disease—PTGS2—muscle cancer	1.25e-05	0.000552	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.17e-05	0.000517	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.15e-05	0.000508	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—FH—muscle cancer	1.14e-05	0.000504	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	1.1e-05	0.000487	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PTCH1—muscle cancer	1.1e-05	0.000487	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	1.08e-05	0.000479	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—MED12—muscle cancer	1.07e-05	0.000472	CbGpPWpGaD
Estradiol—AOX1—Metabolism—PTGS2—muscle cancer	1.05e-05	0.000462	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—MED12—muscle cancer	1.01e-05	0.000446	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—ENO2—muscle cancer	9.75e-06	0.000431	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—FOXO4—muscle cancer	9.47e-06	0.000419	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CNR1—muscle cancer	9.3e-06	0.000411	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—MED12—muscle cancer	9.26e-06	0.000409	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—ENO2—muscle cancer	9.21e-06	0.000407	CbGpPWpGaD
Estradiol—ALB—Metabolism—MED12—muscle cancer	9.21e-06	0.000407	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—FH—muscle cancer	8.79e-06	0.000389	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—ENO2—muscle cancer	8.44e-06	0.000373	CbGpPWpGaD
Estradiol—ALB—Metabolism—ENO2—muscle cancer	8.39e-06	0.000371	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—MED12—muscle cancer	8.26e-06	0.000365	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	8.2e-06	0.000362	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—MED12—muscle cancer	8.07e-06	0.000356	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PTGS2—muscle cancer	7.61e-06	0.000337	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IGF2—muscle cancer	7.6e-06	0.000336	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—MED12—muscle cancer	7.53e-06	0.000333	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ENO2—muscle cancer	7.53e-06	0.000333	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PTGS2—muscle cancer	7.47e-06	0.00033	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—ENO2—muscle cancer	7.35e-06	0.000325	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	7.2e-06	0.000318	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—FOXO1—muscle cancer	7e-06	0.000309	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ENO2—muscle cancer	6.87e-06	0.000304	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	6.6e-06	0.000292	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	6.56e-06	0.00029	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—MED12—muscle cancer	6.44e-06	0.000285	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PTGS2—muscle cancer	5.98e-06	0.000264	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	5.89e-06	0.00026	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ENO2—muscle cancer	5.87e-06	0.000259	CbGpPWpGaD
Estradiol—ALB—Hemostasis—VEGFA—muscle cancer	5.68e-06	0.000251	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PTGS2—muscle cancer	5.58e-06	0.000247	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	5.37e-06	0.000237	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KIT—muscle cancer	5.33e-06	0.000236	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PTGS2—muscle cancer	5.21e-06	0.00023	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PTGS2—muscle cancer	5.12e-06	0.000226	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—MED12—muscle cancer	4.97e-06	0.00022	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PTGS2—muscle cancer	4.74e-06	0.000209	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PTGS2—muscle cancer	4.7e-06	0.000208	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PTGS2—muscle cancer	4.69e-06	0.000207	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.59e-06	0.000203	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ENO2—muscle cancer	4.53e-06	0.0002	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTGS2—muscle cancer	4.37e-06	0.000193	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TP53—muscle cancer	4.29e-06	0.00019	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MDM2—muscle cancer	4.2e-06	0.000186	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTGS2—muscle cancer	3.39e-06	0.00015	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTGS2—muscle cancer	3.21e-06	0.000142	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—VEGFA—muscle cancer	3.19e-06	0.000141	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTGS2—muscle cancer	2.94e-06	0.00013	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTGS2—muscle cancer	2.92e-06	0.000129	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTGS2—muscle cancer	2.62e-06	0.000116	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTGS2—muscle cancer	2.56e-06	0.000113	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TP53—muscle cancer	2.41e-06	0.000106	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTGS2—muscle cancer	2.39e-06	0.000106	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTGS2—muscle cancer	2.04e-06	9.04e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTGS2—muscle cancer	1.58e-06	6.97e-05	CbGpPWpGaD
